Authors
Zinkevich D.A.1, Shostka K.G.1, 2, Belousov A.M.1, Mulendeev S.V.2, Sizonenko N.A.2, Koshelev T.E.3
1 Saint Petersburg State University, Saint Petersburg
2 S.M. Kirov Military Medical Academy, Saint Petersburg
3 North-Western State Medical University named after I.I. Mechnikov, Saint Petersburg
Abstract
This review examines thematic articles published from 2011 to 2025, which examined technical aspects, immediate and long-term results of using microwave ablation for the destruction of primary and secondary malignant liver tumors, and a comparative assessment of various thermal degradation techniques. In the course of reviewing the research results, it was found that the use of microwave ablation (MVA) for the destruction of secondary liver tumors allows achieving similar treatment results with surgical interventions and expands the possibilities of radical surgical treatment in somatically burdened patients.
Keywords: primary and secondary liver tumors, microwave ablation, radiofrequency ablation, surgical treatment, liver resection.
References
1. Malignant neoplasms in Russia in 2023 (morbidity and mortality). A.D. Kaprin, et al, editors. Moscow: P.A. Herzen Moscow Institute of Medical Sciences – branch of the Federal State Budgetary Institution «NMITS of Radiology» of the Ministry of Health of Russia, 2024. 276 p. (In Russ.)
2. Chekmazov IA, Ivanikov IO, Sapronov GV, Kirillova NCh, Vinogradova NN. Liver cancer: etiology, pathogenesis, results of long-term clinical and epidemiological observation. Russian Journal of Evidence-Based Gastroenterology. 2019; 8(1): 5-15. (In Russ., In Engl.) doi: 10.17116/dokgastro201980115.
3. Li F, Zhang YY, Li M, Chen SK. Microwave ablation for liver metastases from colorectal cancer: A comprehensive review of clinical efficacy and safety. World J Gastrointest Surg. 2025; 17(1): 101162. doi: 10.4240/wjgs.v17.i1.101162.
4. Prazdnikov EN, Trandofilov MM, Rudakova MN, Popov AYu, et al. Microwave ablation in the treatment of primary and metastatic liver lesions. Endoscopic Surgery. 2018; 24(4): 18-24. (In Russ.) doi: 10.17116/endoskop20182404118.
5. Вalakhnin PV, Shmelev AS, Shachinov EG. Percutaneous energy ablation of tumors: principles, technologies, result. Practical oncology. 2016; 17(3): 129-153. (In Russ.)
6. Tatli S, Tapan U, Morrison PR, Silverman SG. Radiofrequency ablation: technique and clinical applications. Diagn Interv Radiol. 2012; 18(5): 508-516. doi: 10.4261/1305-3825.DIR.5168-11.1.
7. Maher B, Ryan E, Little M, Boardman P, Stedman B. The management of colorectal liver metastases. Clin Radiol. 2017; 72(8): 617-625. doi: 10.1016/j .crad.2017.05.016.
8. Vasiniotis Kamarinos N, Kaye EA, Sofocleous CT. Image-Guided Thermal Ablation for Colorectal Liver Metastases. Tech Vasc Interv Radiol. 2020; 23(2): 100672. doi: 10.1016/j.tvir.2020.100672.
9. Shi F, Lian S, Mai Q, Mo Z, et al. Microwave ablation after downstaging of hepatocellular carcinoma: outcome was similar to tumor within Milan criteria. Eur Radiol. 2020; 30(5): 2454-2462. doi: 10.1007/s00330-019-06604-y.
10. An C, Cheng Z, Yu X, Han Z, et al. Ultrasound-guided percutaneous microwave ablation of hepatocellular carcinoma in challenging locations: oncologic outcomes and advanced assistive technology. Int J Hyperthermia. 2020; 37(1): 89-100. doi: 10.1080/02656736.2019.1711203.
11. Asvadi NH, Anvari A, Uppot RN, Thabet A, et al. CT-Guided Percutaneous Microwave Ablation of Tumors in the Hepatic Dome: Assessment of Efficacy and Safety. J Vasc Interv Radiol. 2016; 27(4): 496-502; quiz 503. doi: 10.1016/j.jvir.2016.01.010.
12. Hakime A, Yevich S, Tselikas L, Deschamps F, et al. Percutaneous Thermal Ablation with Ultrasound Guidance. Fusion Imaging Guidance to Improve Conspicuity of Liver Metastasis. Cardiovasc Intervent Radiol. 2017; 40(5): 721-727. doi: 10.1007/s00270-016-1561-5.
13. Monfardini L, Orsi F, Caserta R, Sallemi C, et al. Ultrasound and cone beam CT fusion for liver ablation: technical note. Int J Hyperthermia. 2018; 35(1): 500-504. doi: 10.1080/02656736.2018.1509237.
14. Scudamore CH, Patterson EJ, Shapiro AM, Buczkowski AK. Liver tumor ablation techniques. J Invest Surg. 1997; 10(4): 157-164. doi: 10.3109/08941939709032152.
15. Ahmed M, Brace CL, Lee FT Jr, Goldberg SN. Principles of and advances in percutaneous ablation. Radiology. 2011; 258(2): 351-369. doi: 10.1148/ radiol.10081634.
16. Brace C. Thermal tumor ablation in clinical use. IEEE Pulse. 2011; 2(5): 28-38. doi: 10.1109/MPUL.2011.942603.
17. Hinshaw JL, Lubner MG, Ziemlewicz TJ, Lee FT Jr, Brace CL. Percutaneous tumor ablation tools: microwave, radiofrequency, or cryoablation--what should you use and why? Radiographics. 2014; 34(5): 1344-62. doi: 10.1148/rg.345140054.
18. Zivin SP, Gaba RC. Technical and practical considerations for device selection in locoregional ablative therapy. Semin Intervent Radiol. 2014; 31(2): 212-224. doi: 10.1055/s-0034-1373796.
19. Lencioni R, de Baere T, Martin RC, Nutting CW, Narayanan G. Image-Guided Ablation of Malignant Liver Tumors: Recommendations for Clinical Validation of Novel Thermal and Non-Thermal Technologies - A Western Perspective. Liver Cancer. 2015; 4(4): 208-214. doi: 10.1159/000367747.
20. Lubner MG, Brace CL, Hinshaw JL, Lee FT Jr. Microwave tumor ablation: mechanism of action, clinical results, and devices. J Vasc Interv Radiol. 2010; 21(8S): S192-203. doi: 10.1016/j.jvir.2010.04.007.
21. Puijk RS, Ruarus AH, Vroomen LGPH, et al. Colorectal liver metastases: surgery versus thermal ablation (COLLISION) - a phase III single-blind prospective randomized controlled trial. BMC Cancer. 2018; 18(1): 821. doi: 10.1186/s12885-018-4716-8.
22. Izzo F, Granata V, Grassi R, Fusco R, et al. Radiofrequency Ablation and Microwave Ablation in Liver Tumors: An Update. Oncologist. 2019; 24(10): e990-e1005. doi: 10.1634/theoncologist.2018-0337.
23. Chu KF, Dupuy DE. Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat Rev Cancer. 2014; 14(3): 199-208. doi: 10.1038/nrc3672.
24. Krul MF, Gerritsen SL, Vissers FL, Klompenhouwer EG, Ruers TJ, Kuhlmann KF, Kok NF. Radiofrequency versus microwave ablation for intraoperative treatment of colorectal liver metastases. Eur J Surg Oncol. 2022; 48(4): 834-840. doi: 10.1016/j.ejso.2021.10.012.
25. Mimmo A, Pegoraro F, Rhaiem R, Montalti R, et al. Microwave Ablation for Colorectal Liver Metastases: A Systematic Review and Pooled Oncological Analyses. Cancers (Basel). 2022; 14(5): 1305. doi: 10.3390/cancers14051305.
26. Philips P, Groeschl RT, Hanna EM, Swan RZ, et al. Single-stage resection and microwave ablation for bilobar colorectal liver metastases. Br J Surg. 2016; 103(8): 1048-1054. doi: 10.1002/bjs.10159.
27. Tinguely P, Ruiter SJS, Engstrand J, et al. A prospective multicentre trial on survival after Microwave Ablation VErsus Resection for Resectable Colorectal liver metastases (MAVERRIC). Eur J Cancer. 2023; 187: 65-76. doi: 10.1016/j.ejca.2023.03.038.
28. Vietti VN, Duran R, Guiu B, Cercueil JP, et al. Efficacy of microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma in patients with chronic liver disease: a randomised controlled phase 2 trial. Lancet Gastroenterol Hepatol. 2018; 3(5): 317-325. doi: 10.1016/S2468-1253(18)30029-3.
29. Facciorusso A, Abd El Aziz MA, Tartaglia N, et al. Microwave Ablation Versus Radiofrequency Ablation for Treatment of Hepatocellular Carcinoma: A Meta-Analysis of Randomized Controlled Trials. Cancers (Basel). 2020; 12(12): 3796. doi: 10.3390/cancers12123796.
30. Zhang M, Ma H, Zhang J, He L, et al. Comparison of microwave ablation and hepatic resection for hepatocellular carcinoma: a meta-analysis. Onco Targets Ther. 2017; 10: 4829-4839. doi: 10.2147/OTT.S141968.
31. Lucchina N, Tsetis D, Ierardi AM, Giorlando F, et al. Current role of microwave ablation in the treatment of small hepatocellular carcinomas. Ann Gastroenterol. 2016; 29(4): 460-465. doi: 10.20524/aog.2016.0066.
32. Ammori JB, Kemeny NE, Fong Y, Cercek A, et al. Conversion to complete resection and/or ablation using hepatic artery infusional chemotherapy in patients with unresectable liver metastases from colorectal cancer: a decade of experience at a single institution. Ann Surg Oncol. 2013; 20(9): 2901-2907. doi: 10.1245/s10434-013-3009-3.
33. Di Martino M, Rompianesi G, Mora-Guzmán I, et al. Systematic review and meta-analysis of local ablative therapies for resectable colorectal liver metastases. Eur J Surg Oncol. 2020; 46(5): 772-781. doi: 10.1016/j.ejso. 2019.12.003.
34. Gavriilidis P, Roberts KJ, de’Angelis N, Aldrighetti L, Sutcliffe RP. Recurrence and survival following microwave, radiofrequency ablation, and hepatic resection of colorectal liver metastases: A systematic review and network meta-analysis. Hepatobiliary Pancreat Dis Int. 2021; 20(4): 307-314. doi: 10.1016/j.hbpd.2021.05.004.
35. Тan W, Deng Q, Lin S, Wang Y, Xu G. Comparison of microwave ablation and radiofrequency ablation for hepatocellular carcinoma: a systematic review and meta-analysis. Int J Hyperthermia. 2019; 36(1): 264-272. doi: 10.1080/02656736.2018.1562571.
36. Simon CJ, Dupuy DE, Mayo-Smith WW. Microwave ablation: principles and applications. Radiographics. 2005; 25(1): S69-83. doi: 10.1148/rg.25si055501.
37. Meloni MF, Chiang J, Laeseke PF, Dietrich CF, Sannino A, Solbiati M, Nocerino E, Brace CL, Lee FT Jr. Microwave ablation in primary and secondary liver tumours: technical and clinical approaches. Int J Hyperthermia. 2017; 33(1): 15-24. doi: 10.1080/02656736.2016.1209694.
38. Vogl TJ, Nour-Eldin NA, Hammerstingl RM, Panahi B, Naguib NNN. Microwave Ablation (MWA): Basics, Technique and Results in Primary and Metastatic Liver Neoplasms - Review Article. Rofo. 2017; 189(11): 1055-1066. doi: 10.1055/s-0043-117410.
39. Ierardi AM, Floridi C, Fontana F, Chini C, et al. Microwave ablation of liver metastases to overcome the limitations of radiofrequency ablation. Radiol Med. 2013; 118(6): 949-961. doi: 10.1007/s11547-013-0968-1.
40. Della Corte A, Ratti F, Monfardini L, Marra P, et al. Comparison between percutaneous and laparoscopic microwave ablation of hepatocellular carcinoma. Int J Hyperthermia. 2020; 37(1): 542-548. doi: 10.1080/ 02656736.2020.1769869.
41. Vogl TJ, Naguib NN, Gruber-Rouh T, Koitka K, Lehnert T, Nour-Eldin NE. Microwave ablation therapy: clinical utility in treatment of pulmonary metastases. Radiology. 2011; 261(2): 643-651. doi: 10.1148/radiol.11101643.
42. Carrafiello G, Laganà D, Mangini M, Fontana F, et al. Microwave tumors ablation: principles, clinical applications and review of preliminary experiences. Int J Surg. 2008; 6 Suppl 1: S65-69. doi: 10.1016/j.ijsu.2008.12.028.
43. Haier J. Gegenwärtige rechtliche Rahmenbedingungen für den Betrieb und die Nutzung von Biobanken: Teil 1: Rechtsgrundlagen. Chirurg. 2013; 84(9): 785-793. doi: 10.1007/s00104-013-2606-9.
44. Mariak Z, Kochanowicz J, Kordecki K, Jadeszko M, et al. Chirurgiczne usuniecie spirali embolizacyjnej przemieszczonej do tetnicy środkowej mózgu. Neurol Neurochir Pol. 2004; 38(6): 533-537.
45. Liang P, Wang Y, Yu X, Dong B. Malignant liver tumors: treatment with percutaneous microwave ablation--complications among cohort of 1136 patients. Radiology. 2009; 251(3): 933-940. doi: 10.1148/radiol.2513081740.
46. Martin RC, Scoggins CR, McMasters KM. Safety and efficacy of microwave ablation of hepatic tumors: a prospective review of a 5-year experience. Ann Surg Oncol. 2010; 17(1): 171-178. doi: 10.1245/s10434-009-0686-z.
47. Kang TW, Rhim H. Recent Advances in Tumor Ablation for Hepatocellular Carcinoma. Liver Cancer. 2015; 4(3): 176-187. doi: 10.1159/000367740.
